Cytodyn Inc (CYDY)

[Venture_Cap]

Sounds like the FDA wants unquestionable bulletproof data and will leverage human life to get it. Sounds like they were more concerned with the drug arm causing harm which we know already had safety efficacy.

Patients get lost in the protocols.... maybe not “enough” died in the placebo arm to be statistically significant? The baseline non-drug SOC for Covid has improved so death rates have gone down. Had they ran the S2C in New York in March then it would have likely been halted. With that being said the primary endpoint is not as significant as we speculated. Secondary endpoints will be more critical and that’s where LL shines in terms of immunomodulation of CD4/CD8.